Meizhi He
Overview
Explore the profile of Meizhi He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He M, Liu Z, Li L, Liu Y
Nephrol Dial Transplant
. 2023 Dec;
39(5):761-769.
PMID: 38040652
Kidney fibrosis is a common outcome of a wide variety of chronic kidney diseases, in which virtually all kinds of renal resident and infiltrating cells are involved. As such, well-orchestrated...
2.
Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis
Li L, Lu M, Peng Y, Huang J, Tang X, Chen J, et al.
Redox Biol
. 2023 Sep;
67:102868.
PMID: 37690165
Kidney fibrosis is associated with tubular injury, oxidative stress and activation of interstitial fibroblasts. However, whether these events are somehow connected is poorly understood. In this study, we show that...
3.
Li L, He M, Tang X, Huang J, Li J, Hong X, et al.
Kidney Int
. 2023 Feb;
103(6):1063-1076.
PMID: 36805449
The extracellular matrix (ECM) is a complex three-dimensional network of proteins surrounding cells, forming a niche that controls cell adhesion, proliferation, migration and differentiation. The ECM network provides an architectural...
4.
Li L, Liao J, Yuan Q, Hong X, Li J, Peng Y, et al.
Sci Adv
. 2021 Feb;
7(5).
PMID: 33571112
Endothelial cell injury leading to microvascular rarefaction is a characteristic feature of chronic kidney disease (CKD). However, the mechanism underlying endothelial cell dropout is poorly defined. Here, we show a...
5.
Li Y, Bian X, Wei S, He M, Yang Y
Cancer Manag Res
. 2019 Oct;
11:8257-8268.
PMID: 31571983
Pancreatic cancer (PC) is a devastating and lethal malignant disease and it is well known that there is a complex bidirectional relationship between PC and type 2 diabetes mellitus (T2DM)....
6.
Li Y, Zhou Y, Hong Y, He M, Wei S, Yang C, et al.
Front Oncol
. 2019 Jun;
9:441.
PMID: 31192137
Although gemcitabine plus cisplatin (GP) is considered as standard chemotherapy for patients with advanced biliary tract cancer (BTC), the optimal regimen remains unknown. Using Network meta-analysis (NMA), a systematic review...
7.
Li Y, He M, Zhou Y, Yang C, Wei S, Bian X, et al.
Front Pharmacol
. 2019 Mar;
10:139.
PMID: 30873025
Studies evaluating the prognostic significance of programmed death-ligand 1 (PD-L1) expression in colorectal cancer (CRC) are limited and remain controversial. This meta-analysis was conducted in order to evaluate the clinicopathological...
8.
Li Y, Huang Q, Zhou Y, He M, Chen J, Gao Y, et al.
Front Pharmacol
. 2019 Feb;
9:1494.
PMID: 30733677
Programmed cell death ligand 1 (PD-L1) expression has been shown to correlate with poor prognosis in diverse human cancers. However, limited data exist on the prognostic and clinicopathologic significance of...
9.
Li Y, He M, Zou Z, Bian X, Huang X, Yang C, et al.
PeerJ
. 2019 Jan;
6:e6178.
PMID: 30647995
Background: Researches on artificial livers greatly contribute to the clinical treatments for liver failure. This study aimed to evaluate the research output of artificial livers and citations from 2004 to...
10.
Li Y, Bian X, Ouyang J, Wei S, He M, Luo Z
Cancer Manag Res
. 2018 Dec;
10:6949-6959.
PMID: 30588100
Purpose: To develop nomogram models to predict individualized estimates of overall survival (OS) and cancer-specific survival (CSS) in patients with adrenocortical carcinoma (ACC). Patients And Methods: A total of 751...